Overview

The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity

Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
It is planned to investigate the effect of dexrabeprazole on gastric acid primarily, and then gastroesophageal reflux disease (GERD) symptoms, intraesophageal acidity (reflux) and impedance kinetics.
Phase:
Phase 4
Details
Lead Sponsor:
Neutec Ar-Ge San ve Tic A.Ş
Treatments:
Rabeprazole